Skip to main content

Table 7 Change in blood pressure medication and physiologic outcomes at 24 monthsa

From: A community-based lifestyle and weight loss intervention promoting a Mediterranean-style diet pattern evaluated in the stroke belt of North Carolina: the Heart Healthy Lenoir Project

Outcome

Phase 3

12 months to 24 months

Baseline to 24 months

(24 months minus 12 months)

(24 months minus baseline)

n

Mean, 95 % CI

n

Mean, 95 % CI

Blood Pressure Medication

Taking BP lowering medication, %

 All

237

0.4 % (−2.3 to 3.2)

250

0.8 % (−3.0 to 4.6)

  --African American

169

1.2 %(−1.6 to 4.0)

177

1.1 % (−3.3 to 5.6)

  --White

66

0.0 % (−5.9 to 5.9)

71

1.4 % (−5.9 to 8.7)

   --Lifestyle

117

2.6 % (−1.1 to 6.3)

127

1.6 % (−4.2 to 7.3)

   --Wt loss, group

48

2.1 % (−5.0 to 9.1)

51

2.0 % (−6.6 to 10.5)

   --Wt loss, combination

72

−4.2 % (−8.8 to 0.4)

72

−1.4 % (−7.5 to 4.7)

Physiologic

Systolic BP, mm Hg

 LS study only

95

−2.8 (−6.4 to 0.7)

104

−4.2 (−7.3 to 1.2) **

 LS and HBP study

140

−0.2 (−3.8 to 3.5)

146

−9.4 (−13.4 to −5.4) ***

 All

235

−1.3 (−3.9 to 1.3)

250

−7.2 (−9.9 to −4.6) ***

  Subgroup by raceb

  --African American

167

−2.0 (−5.3 to 1.2)

177

−8.4 (−11.8 to −5.1) ***

  --White

66

0.9 (−3.3 to 5.2)

71

−4.1 (−8.5 to 0.4)

Subgroup by interventionc

   --Lifestyle

116

−1.2 (−4.9 to 2.5)

127

−8.8 (−12.9 to −4.8) ***

   --Wt loss, group

47

0.4 (−3.9 to 4.8)

51

−3.9 (−8.4 to 0.6)

   --Wt loss, combination

72

−2.4 (−7.8 to 2.9)

72

−6.8 (−11.8 to −1.9) **

Diastolic BP, mm Hg

 LS study only

95

−3.4 (−5.4 to −1.5) ***

104

−5.2 (−7.1 to −3.3) ***

 LS and HBP study

140

−0.9 (−2.9 to 1.0)

146

−7.8 (−10.1 to −5.5) ***

 All

235

−1.9 (−3.4 to −0.5)

250

−6.7 (−8.3 to −5.1) ***

  --African American

167

−2.4 (−4.2 to 0.5) **

177

−7.2 (−9.2 to −5.1) ***

  --White

66

−1.0 (−3.0 to 1.0)

71

−5.4 (−7.6 to −3.3) ***

   --Lifestyle

116

−1.9 (−4.0 to 0.2)

127

−6.8 (−9.1 to −4.4) ***

   --Wt loss, group

47

−3.1 (−5.8 to −0.4) *

51

−7.7 (−10.7 to −4.6) ***

   --Wt loss, combination

72

−1.3 (−3.9 to 1.3)

72

−6.0 (−8.8 to −3.2) ***

Weight, kg

 All

232

0.1 (−0.6 to 0.8)

247

−1.6 (−2.5 to −0.7) ***

  --African American

164

−0.1 (−1.0 to .08)

174

−1.8 (−2.8 to −0.8) ***

  --White

66

0.6 (−0.6 to 1.7)

71

−1.0 (−2.9 to 0.8)

   --Lifestyle

113

−0.9 (−2.0 to 0.1)

124

−1.7 (−2.9 to −0.5) **

   --Wt loss, group

47

1.2 (−0.4 to 2.8)

51

−2.1 (−4.3 to 0.0) *

   --Wt loss, combination

72

1.0 (−0.2 to 2.2)

72

−1.1 (−2.7 to 0.4)

Weight, ≥ 5 % weight loss, %

 All

232

12 % (8 to 16)

247

23 % (18 to 28)

  --African American

164

12 % (7 to 17)

174

24 % (18 to 31)

  --White

66

12 % (4 to 20)

71

18 % (9 to 27)

   --Lifestyle

113

16 % (9 to 23)

124

23 % (16 to 31)

   --Wt loss, group

47

11 % (2 to 20)

51

25 % (13 to 38)

   --Wt loss, combination

72

7 % (1 to 13)

72

21 % (11 to 30)

Total cholesterol, mg/dLd

 All

196

1 (−3.3 to 5.0)

211

−3 (−7.8 to 1.7)

  --African American

139

−1 (−6.3 to 4.7)

148

−4 (−10.3 to 1.4)

  --White

55

4 (−0.9 to 9.8)

61

1 (−7.3 to 9.2)

   --Lifestyle

91

2 (−4.0 to 8.8)

99

−2 (−8.1 to 4.3)

   --Wt loss, group

41

−3 (−13.7 to 7.2)

46

−9 (−20.9 to 3.7)

   --Wt loss, combination

64

1 (−4.7 to 7.1)

66

−1 (−9.3 to 7.2)

HDL cholesterol, mg/dL

 All

196

0 (−0.8 to 1.3)

211

−1 (−2.3 to 0.3)

  --African American

139

0 (−1.2 to 1.6)

148

−1 (−2.6 to 0.6)

  --White

55

0 (−1.4 to 2.2)

61

−1 (−3.1 to 1.2)

   --Lifestyle

91

0 (−1.4 to 1.7)

99

−2 (−4.0 to −0.1) *

   --Wt loss, group

41

0 (−2.0 to 2.3)

46

1 (−1.6 to 3.6)

   --Wt loss, combination

64

0 (−1.6 to 2.4)

66

−1 (−2.9 to 1.4)

  1. Abbreviations: BP blood pressure, CI confidence interval, HBP high blood pressure, LS lifestyle
  2. Note: Boldface indicates statistical significance *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
  3. SI unit conversion factors: To convert all types of cholesterol to millimoles per liter, multiply by 0.0259
  4. a Data are means except where noted
  5. b 3 categorized as other race
  6. c Participants selected intervention group at 6 month follow-up visit; if they did not attend this visit they were assigned to lifestyle group
  7. d To convert from mg/dL to mmol/L divide by 68.37